Senior Vice President and Chief Financial Officer
Matthew Harbaugh is the senior vice president and chief financial officer at Mallinckrodt Pharmaceuticals. He has executive responsibility for finance and information technology, as well as the Specialty Generics and Nuclear Imaging segments.
Mr. Harbaugh has more than 20 years of experience in controllership, corporate finance, business development and licensing, financial planning and analysis, and investor relations.
Previously, Mr. Harbaugh served as the chief financial officer and interim president of the pharmaceuticals division of Covidien. He has worked as a lead finance executive at Cerberus Capital Management, L.P., a New York-based private equity firm. He also spent 10 years at Monsanto, where he held several positions, including corporate finance director, investor relations manager, and finance director/chief financial officer for the company’s southern Argentine/Chilean and Canadian operations.
Mr. Harbaugh holds a bachelor’s degree in finance from Saint Louis University and an MBA from Northwestern University.